Takeda's $62 billion Shire bid faces November 6 EU antitrust deadline

EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion takeover of London-listed Shire Plc , the European Commission said on Friday.